Another round of COVID-19 vaccines is on the way. The Food and Drug Administration approved vaccines from Pfizer and Moderna that target an omicron subvariant called XBB.1.5. Vaccination campaigns, like this one in San Rafael, Calif., in 2022, could resume soon. Justin Sullivan/Getty Images hide caption
ncG1vNJzZmivp6x7r7zRZ6arn1%2Blv7Cz0ZqkrGeRobluwMeipaCrXZi8r7%2FInZyrnZRkf3F%2BkmhncmdhZnxyfZhxb2ltY219cK3LpWStoJmjtLR5wqilrKGUmr%2BmsIyfpqtlo5q9tbHMm5yrZWFmenN8kWw%3D